1. Home
  2. Bills
  3. H.R. 3537

H.R. 3537 · 117th Congress · 2021–2022

Accelerating Access to Critical Therapies for ALS Act

H.R. 3537 in the 117th Congress (2021–2022) became law — introduced on May 25, 2021, sponsored by Mike Quigley with 331 co-sponsors. Congress held 1 roll call vote on it.

During the 117th Congress (2021–2022), Joe Biden was president, and Democrats held the House majority and Republicans the Senate majority.

Status
Became law
Introduced
May 25, 2021
Co-sponsors
331
Policy area
Health
Public law
Public Law 117-79

What it does

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Mike Quigley (D-IL). Co-sponsors: 186 Democrats, 145 Republicans.

Where it stands

  • IntroducedMay 25, 2021
  • Passed the HouseDec 8, 2021
  • Passed the SenateDec 16, 2021
  • Sent to the PresidentDec 23, 2021
  • Became lawDec 23, 2021

Latest action: Became Public Law No: 117-79. (Dec 23, 2021)

How Congress voted

  • On Motion to Suspend the Rules and Pass, as Amended
    House · Dec 8, 2021 · Passed
    423–3

Every roll call vote on this bill

More bills from Mike Quigley in the 117th Congress

Other Health bills in the 117th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 3537 (117th Congress): Accelerating Access to Critical…,” https://www.capitolreceipts.com/bill/117-hr-3537/accelerating-access-to-critical-therapies-for-als-act (accessed 2026-10-17).